Genomic Insights turns raw sequencing data into actionable clinical intelligence — enabling precision diagnostics, evidence-based treatment decisions, and population-scale risk stratification with unmatched accuracy and speed.
Genomic Insights covers the full analysis pipeline — from variant calling to clinical reporting — in a single integrated platform.
Comprehensive identification and classification of SNVs, indels, CNVs, and structural variants from WGS, WES, and targeted panel data. Aligned to ClinVar, OMIM, and ACMG guidelines.
Population-calibrated risk models across oncology, cardiovascular disease, neurological conditions, and rare disease panels. Ancestry-adjusted scoring for clinical accuracy.
Drug metabolism and efficacy predictions based on individual genetic profiles. Actionable guidance on drug-gene interactions to inform prescribing decisions and avoid adverse events.
Structured, physician-ready reports generated in under 2 minutes — formatted for EMR integration with actionable findings, variant interpretations, and recommended next steps.
Population-scale genomic analysis tools for research institutions — identify statistically significant variant associations across large cohorts with intuitive dashboards.
End-to-end encrypted genomic data handling on AWS with BAA support, role-based access, full audit trails, and data residency controls for enterprise healthcare compliance.
Comprehensive somatic variant analysis for tumor-normal pairs. Identify actionable driver mutations and match patients to targeted therapy options and clinical trials.
Screen for pathogenic variants in genes associated with hypertrophic cardiomyopathy, arrhythmia syndromes, and familial hypercholesterolemia. Cascade testing support included.
Evaluate genetic predisposition to Alzheimer's, Parkinson's, ALS, and other neurodegenerative conditions — enabling early intervention strategies and research enrollment.
WGS-powered analysis to identify ultra-rare variants contributing to undiagnosed conditions. Trio analysis support for pediatric rare disease workups.
Scalable platform for biobank analysis, GWAS, and multi-omics integration. Identify novel disease associations across diverse population cohorts.
Genomic biomarker discovery to identify patient subgroups most likely to respond to investigational therapies — accelerating trial design and improving success rates.
Whether you're a clinical lab, hospital system, or research institution — Genomic Insights integrates into your existing workflows to deliver actionable genomic intelligence at scale.